| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 1397215 | European Journal of Medicinal Chemistry | 2015 | 27 Pages | 
Abstract
												The NS5B polymerase has emerged as an attractive target for the development of antiviral therapy for HCV. This review highlights advances on the synthetic methods of NS5B polymerase inhibitors.
											Related Topics
												
													Physical Sciences and Engineering
													Chemistry
													Organic Chemistry
												
											Authors
												Can Zhao, Yinhu Wang, Shutao Ma, 
											